
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
← Back HomeBrowse every article and treatment insight.

Pain intensity is not the deciding factor for ChondroFiller candidacy; two structural prerequisites apply: documented failure of conservative treatment and MRI-confirmed cartilage damage.

ChondroFiller injection has recorded zero serious adverse effects across more than 19,000 cases since 2013, though the record reflects outcomes only in appropriately selected patients with focal cartilage defects.

ChondroFiller injection—a liquid collagen scaffold that self-polymerises under ultrasound—triggers cartilage regeneration in focal lesions; published data show 70–85% of patients achieve meaningful symptom relief at three to five years in UK private practice.

Thumb basal joint arthritis sits in a treatment gap: corticosteroid injections ease pain for three to four months; surgery is permanent and irreversible. ChondroFiller is a single outpatient injection of acellular collagen that supports the body's own repair.

Advanced bone-on-bone osteoarthritis can be treated with ChondroFiller, an injectable collagen scaffold that self-gels in the joint and recruits the body's own cells for cartilage repair, offering an alternative to joint replacement.

ChondroFiller injection holds regulatory approval in more than 20 European countries but no statutory insurer covers it — the treatment is private-pay everywhere, with costs ranging from £3,000 in London to €2,500–€4,500 across Germany and Austria.

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)